Kolon TissueGene, Inc., formerly KOLON LIFE SCIENCE Inc., is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company operates its business under three main divisions: pharmaceutical business division, eco-friendly chemical division and water treatment solution division. The pharmaceutical business division provides active pharmaceutical ingredients and pharmaceutical intermediates such as loxoprofen sodium, zaltoprofen, flurbiprofen, argatroban, voglibose and others. The eco-friendly chemical division provides antibacterial agents for anti-fouling paints, hair care and other industrial purposes, antioxidants and other chemicals. The water treatment solution division provides water treatment agents. It also involves in the development of new biological drugs such as cell-mediated gene therapies for degenerative arthritis, therapeutic protein drugs for autoimmune disease and others.